Asia-Pacific
Matthew Swinn, who leads the firm’s IP practice, discusses why Mallesons is well-placed to remain a major IP force
Leighton Cassidy Legal hopes to leverage its founder's international experience and provide clients with a rare chance to receive litigation and prosecution under one umbrella
In the final part of a series on challenging patent invalidation decisions in China, lawyers at Spruson & Ferguson and Marshall Gerstein share how courts adjudicate appeals
Mohit and Sidhant Goel decided not to pursue an interim injunction application so that their client, Communications Components Antenna, could benefit from a fast-track trial
Sponsored
Sponsored
-
Sponsored by Remfry & SagarCyril Abrol of Remfry & Sagar reports that India is not confining itself to small steps as the country aims to take a giant leap in the global space race -
Sponsored by FirstLaw PCHyoun-Ja Park and Minji Ryan Kim of FirstLaw PC analyse two significant developments as South Korea attempts to strengthen its protection of trade secrets and proprietary information involving industrial and national core technologies
-
Sponsored by Anand and AnandTusha Malhotra and Tanvi Bhatnagar of Anand and Anand say technological advances such as those in AI are presenting new challenges in protecting the personality rights of celebrities in India and necessitate a delicate balancing act
-
Sponsored by Shiga International Patent OfficeMasato Iida of Shiga International Patent Office explains what types of bio inventions are deemed eligible for patent protection in Japan and draws comparisons with US practice
-
Sponsored by Shiga International Patent OfficeThe Japan Patent Office has published additional case examples designed to clarify the patentability of AI-related technology. Fumio Takahashi of Shiga International Patent Office explains the new guidance
-
Sponsored by Wanhuida Intellectual PropertyA ruling on the inventiveness of a compound patent for a prostate cancer therapeutic could help create uniform jurisprudence regarding the examination of pharmaceutical patents, says Guan Yue of Wanhuida Intellectual Property
